Takeru Fukunaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takeru Fukunaga has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Chie Inoue
Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan
2 shared publicationsNaoko Mukuda
Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
2 shared publicationsShinya Fujii
Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan
2 shared publicationsToshihide Ogawa
Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan
2 shared publicationsAtsushi Murakami
Department of Radiology, Yoka Hospital, 1878-1 Yoka-cho Yoka, Yabu, Hyogo, 667-8555, Japan
1 shared publicationAyumi Kato
Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, Yonago, Japan
1 shared publication
Latest Publications
- Open Access
- 1 January 2019
- Published by Japanese Society for Magnetic Resonance in Medicine in Magnetic Resonance in Medical Sciences
- Vol. 18 (2) , 117-118
A Small Granulosa Cell Tumor of the Ovary Incidentally Detected on Diffusion-weighted Images
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2019
- Published by Japanese Society for Magnetic Resonance in Medicine in Magnetic Resonance in Medical Sciences
- Vol. 18 (2) , 117-118
Open AccessA Small Granulosa Cell Tumor of the Ovary Incidentally Detected on Diffusion-weighted Images
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 18 September 2017
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 35 (12) , 697-706
The spectrum of imaging appearances of müllerian duct anomalies: focus on MR imaging
Müllerian duct anomalies (MDAs) are the result of incomplete development, vertical or lateral fusion, or absorption of the müllerian ducts. The range of anomalies includes uterovaginal agenesis or hypoplasia, unicornuate uterus, uterus didelphys, bicornuate uterus, septate uterus, and arcuate uterus. Correct diagnosis and classification of these anomalies are essential because pregnancy outcomes and treatment options vary between the types of anomaly. Furthermore, early identification of MDAs helps to avoid prolonged symptomatic periods and the complications that may subsequently arise, such as infertility, endometriosis, and neoplasm. Although many of these abnormalities are initially diagnosed by ultrasound or hysterosalpingography, MR imaging is the most accurate noninvasive modality available for classification of the various anomalies because of its better anatomic assessment compared with other diagnostic modalities. Familiarity with the wide variety of MDA presentations can help in the planning of appropriate treatment.
- 18 September 2017
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 35 (12) , 697-706
The spectrum of imaging appearances of müllerian duct anomalies: focus on MR imaging
Müllerian duct anomalies (MDAs) are the result of incomplete development, vertical or lateral fusion, or absorption of the müllerian ducts. The range of anomalies includes uterovaginal agenesis or hypoplasia, unicornuate uterus, uterus didelphys, bicornuate uterus, septate uterus, and arcuate uterus. Correct diagnosis and classification of these anomalies are essential because pregnancy outcomes and treatment options vary between the types of anomaly. Furthermore, early identification of MDAs helps to avoid prolonged symptomatic periods and the complications that may subsequently arise, such as infertility, endometriosis, and neoplasm. Although many of these abnormalities are initially diagnosed by ultrasound or hysterosalpingography, MR imaging is the most accurate noninvasive modality available for classification of the various anomalies because of its better anatomic assessment compared with other diagnostic modalities. Familiarity with the wide variety of MDA presentations can help in the planning of appropriate treatment.
- Open Access
- 19 August 2014
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 41 (6) , 1662-1668
Accuracy of semiquantitative dynamic contrast‐enhanced MRI for differentiating type II from type I endometrial carcinoma
Purpose: To investigate type II endometrial carcinoma characterization using dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) and evaluate the diagnostic accuracy of semiquantitative DCE‐MRI in differentiating type II from type I tumors.Materials and Methods: Seventy‐seven patients with endometrial carcinoma were retrospectively evaluated using 3T DCE‐MRI. The maximum absolute enhancement of signal intensity (SImax), maximum relative enhancement (SIrel), wash‐in rate (WIR), and the SImax/SI (piriformis) ratio were analyzed. To differentiate type I from type II tumors, optimal threshold criteria were established. The Mann–Whitney U‐test was used for statistical comparison and receiver operating characteristic curve analysis was used to determine optimal cutoff values.Results: The SIrel (P < 0.001), WIR (P < 0.0001), and SImax/SI (piriformis) ratio (P < 0.0001), but not SImax, differed significantly between type I and type II carcinomas. Cutoff values of SIrel ≥58.8, WIR ≥37.0, and SImax/SI (piriformis) ratio ≥1.55 had sensitivities of 93%, 93%, and 67%, specificities of 60%, 60%, and 79%, accuracies of 66%, 66%, and 67%, respectively, for predicting type II endometrial carcinoma.Conclusion: Endometrial carcinoma with strong (high level) enhancement on DCE‐MRI is suggestive of type II endometrial carcinoma. Semiquantitative evaluation of DCE‐MRI may be useful for differentiating type II from type I tumors. J. Magn. Reson. Imaging 2015;41:1662–1668. © 2014 Wiley Periodicals, Inc.
- 19 August 2014
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 41 (6) , 1662-1668
Open AccessAccuracy of semiquantitative dynamic contrast‐enhanced MRI for differentiating type II from type I endometrial carcinoma
Purpose: To investigate type II endometrial carcinoma characterization using dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) and evaluate the diagnostic accuracy of semiquantitative DCE‐MRI in differentiating type II from type I tumors.Materials and Methods: Seventy‐seven patients with endometrial carcinoma were retrospectively evaluated using 3T DCE‐MRI. The maximum absolute enhancement of signal intensity (SImax), maximum relative enhancement (SIrel), wash‐in rate (WIR), and the SImax/SI (piriformis) ratio were analyzed. To differentiate type I from type II tumors, optimal threshold criteria were established. The Mann–Whitney U‐test was used for statistical comparison and receiver operating characteristic curve analysis was used to determine optimal cutoff values.Results: The SIrel (P < 0.001), WIR (P < 0.0001), and SImax/SI (piriformis) ratio (P < 0.0001), but not SImax, differed significantly between type I and type II carcinomas. Cutoff values of SIrel ≥58.8, WIR ≥37.0, and SImax/SI (piriformis) ratio ≥1.55 had sensitivities of 93%, 93%, and 67%, specificities of 60%, 60%, and 79%, accuracies of 66%, 66%, and 67%, respectively, for predicting type II endometrial carcinoma.Conclusion: Endometrial carcinoma with strong (high level) enhancement on DCE‐MRI is suggestive of type II endometrial carcinoma. Semiquantitative evaluation of DCE‐MRI may be useful for differentiating type II from type I tumors. J. Magn. Reson. Imaging 2015;41:1662–1668. © 2014 Wiley Periodicals, Inc.